H. Tillmann
Aug 1, 2007
Citations
0
Influential Citations
17
Citations
Journal
Current opinion in investigational drugs
Abstract
Metabasis Therapeutics Inc (previously Ribapharm Inc) is developing pradefovir, an oral liver-targeting prodrug of adefovir developed using its HepDirect technology, for the potential treatment of HBV infection. Phase II clinical trials of pradefovir have been completed.